Biologic Warfare Defense Research and Endemic Infectious Diseases

Research: Whence and why the dichotomy

COL John F. Glenn, Ph.D.

Deputy for Research and Development

U.S. Army Medical Research and Materiel Command




Discussion with Sponsor:

Current challenges

Overview of the challenges to adequate vaccine strategy presented by industry and DoD policies and constraints

Overview of the regulatory parameters that currently affect military vaccine strategy

Discussion of what the U.S. Army seeks to gain from this committee report

Discussion of charge


Break, end of open session

Meeting II

June 19 and 20, 2000

The Foundry Building, Washington, D.C.

19 June 2000


Welcome and Introduction

Stanley Lemon, M.D., Chair


Examples of the Impact of Vaccine Preventable Infectious Disease:


Impact of Recent Adenovirus Outbreaks in Military Training Centers

CAPT Gregory Gray, M.D., M.P.H.

Director, DoD Center for Deployment Health Research

Naval Health Research Center, San Diego


Lt Col James Neville, M.D., M.P.H.

Chief, Force Health Protection and Surveillance Branch

U.S. Air Force Institute for Environment, Safety & Occupational

Health Risk Analysis

Brooks Air Force Base

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement